Zugriffe | |
---|---|
Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis | 89 |
April 2024 | Mai 2024 | Juni 2024 | Juli 2024 | August 2024 | September 2024 | Oktober 2024 | |
---|---|---|---|---|---|---|---|
Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis | 1 | 3 | 2 | 3 | 4 | 0 | 0 |
Zugriffe | |
---|---|
2020_Burmester_etal.pdf | 38 |